Notably, CAMK2A exhibited higher expression in normal lung tissues, whereas CHMP4C and PYGB were markedly overexpressed in LUSC, with their dysregulation associated with poorer clinical outcomes and a potential role in tumor progression and metastasis. Here, CHMP4C is linked to neoplasm.